Literature DB >> 21543630

Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.

L M Hollestein1, S A W van den Akker, T Nijsten, H E Karim-Kos, J W Coebergh, E de Vries.   

Abstract

BACKGROUND: It has been debated that the epidemic of melanoma is largely due to overdiagnosis, since increases in incidence were mainly among thin melanomas and mortality rates remained stable. Our objective was to examine this controversy in The Netherlands. PATIENTS AND METHODS: Information on newly diagnosed melanoma patients was obtained from The Netherlands Cancer Registry. European Standardized Rates and estimated annual percentage change were calculated for the period 1989-2008. Cohort-based, period-based and multivariate survival analyses were carried out.
RESULTS: The incidence rate of melanoma increased with 4.1% (95% confidence interval 3.6-4.5) annually. Incidence rates of both thin melanomas (≤ 1 mm) and thick melanomas (> 4 mm) increased since 1989. Mortality rates increased mainly in older patients (> 65 years). Ten-year relative survival of males improved significantly from 70% in 1989-1993 to 77% in 2004-2008 (P < 0.001) and for females the 10-year relative survival increased from 85% to 88% (P < 0.01). Recently diagnosed patients had a better prognosis even after adjusting for all known prognostic factors.
CONCLUSION: Since incidence of melanomas among all Breslow thickness categories increased as well as the mortality rates, the melanoma epidemic in The Netherlands seems to be real and not only due to overdiagnosis.

Entities:  

Mesh:

Year:  2011        PMID: 21543630     DOI: 10.1093/annonc/mdr128

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  16 in total

1.  Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?

Authors:  Susana Puig; Joaquim Marcoval; Cristina Paradelo; Antoni Azon; Ramon Bartralot; Susana Bel; Xavier Bigata; Aram Boada; Antoni Campoy; Cristina Carrera; Neus Curco; Joan Dalmau; Carlos Ferrándiz; Josep R Ferreres; Manel Formigon; Fernando Gallardo; Alberto Gonzalez; Miquel Just; Enric Llistosella; Rosa M Marti; M Elena Nogues; Ramon Pedragosa; Josep A Pujol; Rodrigo Roldán-Marín; Mireia Sabat; Montserrat Salleras; Juan A Smandia; Pedro Zaballos; Estel Plana; Josep Malvehy
Journal:  Acta Derm Venereol       Date:  2015-04       Impact factor: 4.437

2.  University Hospital Waterford: 5-year experience of cutaneous melanoma.

Authors:  R Sehgal; C X Cheung; R Alradadi; D A Healy; R Landers; G T O'Donoghue
Journal:  Ir J Med Sci       Date:  2016-11-21       Impact factor: 1.568

3.  Limited role for histopathological examination of re-excision specimens of completely excised melanomas.

Authors:  A C de Waal; R Vossen; K K H Aben; L A L M Kiemeney; M M van Rossum; W A M Blokx
Journal:  Virchows Arch       Date:  2014-05-29       Impact factor: 4.064

4.  [Tumorogenesis and skin tumours in the elderly].

Authors:  T Wild; A Altenburg; I Karagiannidis; C Mauch; C C Zouboulis
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

5.  Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study.

Authors:  J Rubió-Casadevall; M Puig-Vives; M Puigdemont; L Vilardell; A Carbó-Bagué; R Marcos-Gragera; N Vilar-Coromina
Journal:  Clin Transl Oncol       Date:  2018-06-05       Impact factor: 3.405

6.  Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.

Authors:  S Kruijff; E Bastiaannet; A B Francken; M Schaapveld; M van der Aa; H J Hoekstra
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

7.  Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma.

Authors:  M J Rutherford; L Ironmonger; N Ormiston-Smith; G A Abel; D C Greenberg; G Lyratzopoulos; P C Lambert
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  Increasing Costs of Skin Cancer due to Increasing Incidence and Introduction of Pharmaceuticals, 2007-2017.

Authors:  Eline Noels; Loes Hollestein; Kees Luijkx; Marieke Louwman; Carin de Uyl-de Groot; Renate van den Bos; Astrid van der Veldt; Dirk Grünhagen; Marlies Wakkee
Journal:  Acta Derm Venereol       Date:  2020-05-28       Impact factor: 3.875

9.  Skin lesions suspected of malignancy: an increasing burden on general practice.

Authors:  Cecile J L Koelink; Boudewijn J Kollen; Feikje Groenhof; Klaas van der Meer; Wouter K van der Heide
Journal:  BMC Fam Pract       Date:  2014-02-12       Impact factor: 2.497

10.  The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.

Authors:  Samantha Damude; Josette E H M Hoekstra-Weebers; Anne Brecht Francken; Sylvia Ter Meulen; Esther Bastiaannet; Harald J Hoekstra
Journal:  Ann Surg Oncol       Date:  2016-05-18       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.